Dr. Lalani is an Assistant Professor at McMaster University and a Medical Oncologist at the Juravinski Cancer Centre. After residency training, he was awarded the TD Insurance Meloche Monnex & Alberta Medical Association Scholarship. He pursued a Fellowship in Genitourinary Oncology at Dana-Farber Cancer Institute in Boston, mentored by Dr. Toni Choueiri. He has also completed the Program in Clinical Effectiveness at the Harvard T.H. Chan School of Public Health. He is a member of the Escarpment Cancer Research Institute, and an Associate Member of the Centre for Discovery in Cancer Research (CDCR) at McMaster University.
His academic interests include clinical trial design and translational work for genitourinary malignancies. He was awarded the Elizabeth Eisenhauer Early Drug Development Young Investigator Award 2022, from the Canadian Cancer Trials Group. He is the lead PI for the CYTOSHRINK clinical trial.